Nutritional support of the pediatric oncology patient.
The child with a malignancy frequently will have associated cachexia with significant weight loss and malnutrition. The reasons for this are multifactorial and may be related directly to the tumor, such as increased metabolic rate, circulating peptides leading to anorexia, and decreased intake due to poor appetite or gut involvement. There appears to be other reasons involved, including increased whole body protein breakdown, increased lipolysis, and increased gluconeogenesis. Release of certain cytokines, such as tumor necrosis factor, interleukin-1, interleukin-6, and others may increase the cancer cachexia. Malnutrition in these children leads to intolerance of chemotherapy and radiotherapy as well as increased local and systemic infections. For many years, oncologists were hesitant to provide nutrition support to cancer patients for fear that tumor growth would be enhanced. Pediatric oncologists learned early that starvation plays no positive role in cancer therapy. Adjunctive nutritional support, either enterally or parenterally, supports the patient during therapy with surgery, chemotherapy, or radiation. Many studies have now shown that the nutritionally replete patient tolerates therapy better and in some pediatric malignancies may enhance survival.
Andrassy
R J
RJ
Department of Surgery, University of Texas-Houston Medical School and Pediatric Surgery, USA.
Chwals
W J
WJ
D002100:Cachexia; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009369:Neoplasms / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D009748:Nutrition Disorders; D018529:Nutritional Support